This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Juan Antonio Gamboa: Innovator in Pharmaceutical Chemistry
Introduction
Juan Antonio Gamboa is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target central nervous system diseases.
Latest Patents
Gamboa holds a patent for "Substituted 1H-pyrrolo[2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase Iε." This invention discloses and claims compounds of formula (I), wherein M is N, and K and L are each C, with the remaining substituents further defined. These compounds are effective as inhibitors of human casein kinase Iε, making them useful in treating mood disorders and sleep disorders. The patent also includes pharmaceutical compositions comprising these compounds and methods for their preparation.
Career Highlights
Gamboa is currently associated with Aventis Pharmaceuticals Inc., where he continues to innovate in the pharmaceutical sector. His work has led to advancements in treatments for various central nervous system disorders.
Collaborations
Some of his notable coworkers include William Arthur Metz, Jr. and Frank Halley. Their collaborative efforts have contributed to the success of various projects within the company.
Conclusion
Juan Antonio Gamboa is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of significant health issues. His innovative compounds and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile